Regulations.gov document
Proposal to Withdraw Approval for the Breast Cancer Indication for Bevacizumab (Avastin)…
Other · FDA-2010-N-0621 · posted Nov 3, 2011
Key facts
| Document ID | FDA-2010-N-0621-0538 |
|---|---|
| Title | Proposal to Withdraw Approval for the Breast Cancer Indication for Bevacizumab (Avastin) Public Hearing June 29, 2011 - Transcript |
| Document type | Other |
| Subtype | Transcript(s) |
| Agency | FDA |
| Docket | FDA-2010-N-0621 |
| Posted | Nov 3, 2011 |
| Comment period opens | Nov 3, 2011 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: